Frequent monoallelic loss of D13S319 in multiple myeloma patients shown by interphase fluorescence in situ hybridization

被引:38
作者
Chang, H
Bouman, D
Boerkoel, CF
Stewart, AK
Squire, JA
机构
[1] Toronto Hosp, Div Hematol, Toronto, ON, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[3] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[4] Hosp Sick Children, Canc Cytogenet Program, Toronto, ON M5G 1X8, Canada
[5] Hosp Sick Children, Ontario Canc Inst, Toronto, ON M5G 1X8, Canada
[6] Hosp Sick Children, Div Clin Genet, Toronto, ON M5G 1X8, Canada
关键词
tumor suppressor gene; deletion; chromosome; 13; hematological malignancy; FISH; toss of heterozygosity;
D O I
10.1038/sj.leu.2401208
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Deletions or monosomy of chromosome 13 are frequent in multiple myeloma (MM). A candidate tumor suppressor gene might reside telomeric of the retinoblastoma gene (RBI) at band 13q14 and to play a role in B cell neoplasm. The D13S319 locus, between RBI and D13S25 loci at 13q14 is the most commonly deleted marker in chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma (NHL). We evaluated the D13S319 locus in 24 MM cases by fluorescence in situ hybridization (FISH). We observed monosomy for D13S319 in 6/20 (30%) MM patients with an apparently normal karyotype. As expected, in four karyotypically abnormal MM cases with partial or complete monosomy for chromosome 13, all of them had monoallelic loss of D13S319. Our results indicated that the loss of D13S319 is commonly found in MM, even at diagnosis, and is more frequent than predicted based on conventional cytogenetic analysis of metaphase spreads. This finding implicates a candidate tumor suppressor gene at 13q14 in the pathogenesis of MM.
引用
收藏
页码:105 / 109
页数:5
相关论文
共 25 条
[1]  
Batch MJ, 1997, AGT CYTOGENETIC LAB
[2]   EVIDENCE FOR A NEW TUMOR SUPPRESSOR LOCUS (DBM) IN HUMAN B-CELL NEOPLASIA TELOMERIC TO THE RETINOBLASTOMA GENE [J].
BROWN, AG ;
ROSS, FM ;
DUNNE, EM ;
STEEL, CM ;
WEIRTHOMPSON, EM .
NATURE GENETICS, 1993, 3 (01) :67-72
[3]   Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia [J].
Bullrich, F ;
Veronese, ML ;
Kitada, S ;
Jurlander, J ;
Caligiuri, MA ;
Reed, JC ;
Croce, CM .
BLOOD, 1996, 88 (08) :3109-3115
[4]   ALTERED EXPRESSION OF THE RETINOBLASTOMA GENE-PRODUCT IN HUMAN SARCOMAS [J].
CANCE, WG ;
BRENNAN, MF ;
DUDAS, ME ;
HUANG, CM ;
CORDONCARDO, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (21) :1457-1462
[5]   THE GENETIC-BASIS OF CANCER [J].
CAVENEE, WK ;
WHITE, RL .
SCIENTIFIC AMERICAN, 1995, 272 (03) :72-79
[6]  
Cuneo A, 1997, HAEMATOLOGICA, V82, P85
[7]  
DAO DD, 1994, LEUKEMIA, V8, P1280
[8]  
DEWALD GW, 1985, BLOOD, V66, P380
[9]   INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION IDENTIFIES CHROMOSOMAL-ABNORMALITIES IN PLASMA-CELLS FROM PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE [J].
DRACH, J ;
ANGERLER, J ;
SCHUSTER, J ;
ROTHERMUNDT, C ;
THALHAMMER, R ;
HAAS, OA ;
JAGER, U ;
FIEGL, M ;
GEISSLER, K ;
LUDWIG, H ;
HUBER, H .
BLOOD, 1995, 86 (10) :3915-3921
[10]  
DRACOPOLI NC, 1905, CURRENT PROTOCOLS HU